Loading...
The Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human Primates
There are currently no approved medical radiation countermeasures (MRC) to reduce the lethality of high-dose total body ionizing irradiation expected in nuclear emergencies. An ideal MRC would be effective even when administered well after radiation exposure and would counteract the effects of irrad...
Saved in:
| Published in: | PLoS One |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Public Library of Science
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4569586/ https://ncbi.nlm.nih.gov/pubmed/26367124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0135388 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|